References
- Behr C, Goltzene MA, Kosmalski G, et al. Epidemiology of epilepsy. Rev Neurol. 2016;172(1):27–36.
- Engel J Jr. What can we do for people with drug-resistant epilepsy? The 2016 Wartenberg lecture. Neurology. 2016;87(23):2483–2489.
- Wiebe S, Jette N. Pharmacoresistance and the role of surgery in difficult to treat epilepsy. Nat Rev Neurol. 2012;8(12):669–677.
- Cramer JA, Wang ZJ, Chang E, et al. Healthcare utilization and costs in adults with stable and uncontrolled epilepsy. Epilepsy Behav. 2014;31:356–362.
- Villanueva V, Giron JM, Martin J, et al. Quality of life and economic impact of refractory epilepsy in Spain: the ESPERA study. Neurologia. 2013;28(4):195–204.
- Malyshev SM, Alekseeva TM. Quality of life and its determinants in patients with drug resistant focal epilepsy. Èpilepsiâ Paroksizmal′nye Sostoâ. 2021;12(4):216–225.
- Akdemir V, Sut N, Guldiken B. Factors affecting the quality of life in drug-resistant epilepsy patients. Acta Neurol Belg. 2016;116(4):513–518.
- Englot DJ, Han SJ, Rolston JD, et al. Epilepsy surgery failure in children: a quantitative and qualitative analysis. J Neurosurg Pediatr. 2014;14(4):386–395.
- Englot DJ, Lee AT, Tsai C, et al. Seizure types and frequency in patients who “fail” temporal lobectomy for intractable epilepsy. Neurosurgery. 2013;73(5):838–844; quiz 844.
- Englot DJ, Raygor KP, Molinaro AM, et al. Factors associated with failed focal neocortical epilepsy surgery. Neurosurgery. 2014;75(6):648–645;discussion 655; quiz 656.
- Englot DJ. A modern epilepsy surgery treatment algorithm: incorporating traditional and emerging technologies. Epilepsy Behav. 2018;80:68–74.
- Kuba R, Brazdil M, Kalina M, et al. Vagus nerve stimulation: longitudinal follow-up of patients treated for 5 years. Seizure. 2009;18(4):269–274.
- Markert MS, Fisher RS. Neuromodulation – science and practice in epilepsy: vagus nerve stimulation, thalamic deep brain stimulation, and responsive NeuroStimulation. Expert Rev Neurother. 2019;19(1):17–29.
- Nair DR, Laxer KD, Weber PB, et al. Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy. Neurology. 2020;95(9):e1244–e1256.
- Razavi B, Rao VR, Lin C, et al. Real-world experience with direct brain-responsive neurostimulation for focal onset seizures. Epilepsia. 2020;61(8):1749–1757.
- Watson Health. IBM MarketScan research databases for life sciences researchers [White Paper]. IBM Corporation. Available from: https://www.ibm.com/downloads/cas/OWZWJ0QO
- Quan H, Li B, Couris CM, et al. Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682.
- Coppola G, Operto FF, Matricardi S, et al. Monitoring and managing depression in adolescents with epilepsy: current perspectives. Neuropsychiatr Dis Treat. 2019;15:2773–2780.
- Hermann BP, Seidenberg M, Bell B. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia. 2000;41(Suppl 2):S31–S41.
- Kanner AM. Depression in epilepsy: a neurobiologic perspective. Epilepsy Curr. 2005;5(1):21–27.
- Glen S. Greedy algorithm & greedy matching in statistics. Available from: https://www.statisticshowto.com/greedy-algorithm-matching/
- Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424.
- Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457–481.
- Bureau of Labor Statistics. Consumer price index, BLS Data Viewer [cited 2021 Jul 15]. Available from: https://beta.bls.gov/dataViewer/view/timeseries/CUUR0000SAM
- Wong S, Mani R, Danish S. Comparison and selection of current implantable anti-Epileptic devices. Neurotherapeutics. 2019;16(2):369–380.
- Zhang L, Wu JY, Lam SK. Comparison of healthcare resource utilization in pediatric patients with refractory epilepsy: vagus nerve stimulation and medical treatment cohorts. Epilepsy Behav. 2021;123:108281.
- US Food and Drug Administration. Summary of safety and effectiveness data: VNS Therapy™ System [cited 2022 Jun 17]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf/p970003s050b.pdf
- Ellens NR, Elisevich K, Burdette DE, et al. A comparison of vagal nerve stimulation and responsive neurostimulation for the treatment of medically refractory complex partial epilepsy. Stereotact Funct Neurosurg. 2018;96(4):259–263.
- Janke AT, Mei H, Rothenberg C, et al. Analysis of hospital resource availability and COVID-19 mortality across the United States. J Hosp Med. 2021;16(4):E1–E4.
- Bravata DM, Perkins AJ, Myers LJ, et al. Association of intensive care unit patient load and demand with mortality rates in US department of veterans affairs hospitals during the COVID-19 pandemic. JAMA Netw Open. 2021;4(1):e2034266.
- Czeisler ME, Marynak K, Clarke KEN, et al. Delay or avoidance of medical care because of COVID-19-related concerns – United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(36):1250–1257.
- Rincon N, Barr D, Velez-Ruiz N. Neuromodulation in drug resistant epilepsy. Aging Dis. 2021;12(4):1070–1080.
- Warren AEL, Dalic LJ, Thevathasan W, et al. Targeting the centromedian thalamic nucleus for deep brain stimulation. J Neurol Neurosurg Psychiatry. 2020;91(4):339–349.
- Medtronic. Indications, safety, and warnings: deep brain stimulation therapy. Available from: https://www.medtronic.com/us-en/healthcare-professionals/therapies-procedures/neurological/deep-brain-stimulation/indications-safety-warnings.html
- NeuroPace. NeuroPace® RNS® System patient manual [cited 2022 Jan 13]. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf10/p100026c.pdf
- VNS Therapy. Patient’s guide for epilepsy; 2020.
- Helmers SL, Thurman DJ, Durgin TL, et al. Descriptive epidemiology of epilepsy in the U.S. population: a different approach. Epilepsia. 2015;56(6):942–948.
- Jette N, Reid AY, Quan H, et al. How accurate is ICD coding for epilepsy? Epilepsia. 2010;51(1):62–69.
- Kee VR, Gilchrist B, Granner MA, et al. Systematic review of validated methods for identifying seizures, convulsions, or epilepsy using administrative and claims data. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):183–193.
- Pan I, LoPresti MA, Clarke DF, et al. The effectiveness of medical and surgical treatment for children with refractory epilepsy. Neurosurgery. 2020;88(1):E73–E82.
- Pestana Knight EM, Schiltz NK, Bakaki PM, et al. Increasing utilization of pediatric epilepsy surgery in the United States between 1997 and 2009. Epilepsia. 2015;56(3):375–381.
- Englot DJ, Chang EF, Auguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg. 2011;115(6):1248–1255.
- Kurth T, Lewis BE, Walker AM. Health care resource utilization in patients with active epilepsy. Epilepsia. 2010;51(5):874–882.
- Fitch K, Pan X, Lau J, et al. Prevalence and economic burden of epilepsy in the institutionalized medicare fee-for-service population. Business. 2019;12(3):151–158.